Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-14-Speech-1-198-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110214.18.1-198-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, I would like to talk about the issue of collecting and storing cord blood, which is a major source of stem cells. Through the collection of cord blood at birth, which, in the past, used to be discarded with the placenta, we can obtain a significant source of undifferentiated stem cells without causing discomfort to the mother or child, and these can be modulated and used successfully at any time in the future to treat leukaemia and at least 70 other conditions. I would like to ask why it is that in Europe, we collect less than 1% of stem cells at birth, and I would like, of course, to agree with the Commissioner, who says that it is mainly up to Member States to regulate this, although the Commission, along with the Member States, could surely help to improve the provision of information to parents concerning the advantages of stem cells, in light of progress in stem cell therapy and regenerative medicine. I say this as a former rapporteur for the directive on advanced therapies."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples